The primary objectives of this study are to assess the sensitivity and specificity of SGM-101 in detecting non-small cell lung carcinomas during surgery when excited by an near-infrared light source utilizing intraoperative imaging.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sensitivity measure of SGM-101 uptake and expression in identifying non-small cell lung cancer
Timeframe: Up to 10 days post surgery (completion of pathology report)
Specificity measure of SGM-101 uptake and expression in identifying non-small cell lung cancer
Timeframe: Up to 10 days post surgery (completion of pathology report)
Number of Adverse Events (AEs) and Treatment-emergent Adverse Events (TEAEs)
Timeframe: Up to 4 weeks post surgery (completion of post-operative follow-up visit)